|
|
 |
|
Viewing report
|
|
|
|
Allergy and Asthma Therapeutics Markets: U.S.
Frost & Sullivan, May 1997
This report on the U.S. markets for allergy and asthma therapeutics includes allergy symptomatic treatment (single-entity antihistamines, antihistamine and decongestant combinations, single-entity topical corticosteroids, nasal corticosteroids, and ophthalmic anti-allergy agents), anti-asthma treatment (sympathomimetics, single-entity xanthines, anticholinergics, inhaled corticosteroids, mast cell stabilizers, and systemic corticosteroids), allergy diagnostic and immunotherapy (allergy diagnostics, and immunotherapy), and anti-asthma medical devices (nebulizers and peak-flow monitors).
Customers who bought this item also bought
European Asthma Therapeutics Markets
U.S. Asthma Therapeutics Market
Asthma & COPD Therapeutics
Allergy Drug Pipeline and R&D 2009
Asthma Therapeutics - Global Strategic Business Report
Allergy Drug Pipeline and R&D 2009
Asthma Therapeutics: New Treatment Options and Emerging Drug Discovery Targets
U.S. Asthma Therapies Markets
Stakeholder Opinions: Asthma Phenotypes A Changing Paradigm
Allergy Therapeutics Plc
Allergy Therapeutics plc - Financial and Strategic Analysis Review
Commercial Insight: Asthma & COPD - On the verge of generic entry
|
|
|
|
